| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/24/2008 | WO2008048801A2 Phenylalkylamino carbamate compositions |
| 04/24/2008 | WO2008048784A1 Pegylated pth as pth receptor modulators and uses thereof |
| 04/24/2008 | WO2008047948A1 Block copolymer for drug complex and pharmaceutical composition |
| 04/24/2008 | WO2008047904A1 Therapeutic agent for occlusive peripheral vascular disease, and use thereof |
| 04/24/2008 | WO2008047863A1 Sustained release preparation for tissue regeneration therapy |
| 04/24/2008 | WO2008047857A1 METHOD OF PRODUCING COMPOSITION COMPRISING HARDLY WATER-SOLUBLE COMPOUND ENCLOSED IN HYDROPHILIC MATRIX AND PREPARATION FOR EXTERNAL USE COMPRISING ANTICANCER AGENT OR DRUG HAVING OCTANOL/WATER PARTITION COEFFICIENT (Log P) OF -3.0 OR MORE BUT NOT MORE THAN 3.0 ENCLOSED IN HYDROPHILIC BASE |
| 04/24/2008 | WO2008047680A1 External preparation for skin |
| 04/24/2008 | WO2008047559A1 Highly water-dispersible powder and method of producing the same |
| 04/24/2008 | WO2008047548A1 Metal-containing fine particle |
| 04/24/2008 | WO2008047391A1 Nutriceutic composition comprising lactoferrin and proteasic probiotics |
| 04/24/2008 | WO2008047345A1 Dendrimeric platform for controlled release of drugs |
| 04/24/2008 | WO2008047057A1 Method for preparing cyclodextrin oligomers or polymers, products obtained and uses |
| 04/24/2008 | WO2008046905A1 Micellar nanoparticles of chemical substances |
| 04/24/2008 | WO2008046606A2 Topical composition for the treatment of eczema |
| 04/24/2008 | WO2008046357A1 Aqueous solution containing sodium pyruvate, preparation method and use thereof |
| 04/24/2008 | WO2008025563A3 Polymer matrix, method for its production, and its use |
| 04/24/2008 | WO2008021412A3 Interferon beta and transferrin fusion proteins |
| 04/24/2008 | WO2008016300A3 Antibiotic composition |
| 04/24/2008 | WO2008001166A3 Process for synthesis of glycomimicking cationic amphiphiles |
| 04/24/2008 | WO2007132355A3 Compositions and methods for inhibiting viral adhesion |
| 04/24/2008 | WO2007117222A8 Biodegradable thermogelling polymer |
| 04/24/2008 | WO2007113687A3 Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same |
| 04/24/2008 | WO2007011874A3 Formulation and method for administration of ophthalmologically active agents |
| 04/24/2008 | WO2006079099A3 Method of conjugating aminothiol containing molecules to a polymer |
| 04/24/2008 | US20080097087 Micelles; complexes; stability; MALDI-TOF-MS |
| 04/24/2008 | US20080097083 Granulocyte cell stimulating factor (G-CSF), erythropoietin, interferon, and growth hormone |
| 04/24/2008 | US20080096982 evaluating bucindolol treatment for patient with heart failure; whether to administer bucindolol based on if the patient is homozygous for the Arg 389 polymorphism in the .beta.1-adrenergic receptor; bucindolol not indicated wherein the patient is a Del322-325 carrier in alpha2cAR; pharmacogenetics |
| 04/24/2008 | US20080096980 which cause various pathologies including Parkinson's, Huntington's, and Alzheimer's Diseases; agent that induces a survival response by the cell; induces sequestration of toxic protein in an inclusion body; |
| 04/24/2008 | US20080096979 Aqueous Pharmaceutical Coating |
| 04/24/2008 | US20080096978 Hydrogen peroxide, sodium perborate, sodium peroxide or urea peroxide, a non-clouding stabilizer chosen from diethylene triamine penta(methylene phosphonic acid) and 1-hydroxyethylidene-1,1-diphosphonic acid, and hydroxypropyl methyl cellulose and sodium carboxymethyl cellulose |
| 04/24/2008 | US20080096977 Biocompatible phase invertable proteinaceous compositions and methods for making and using the same |
| 04/24/2008 | US20080096976 Method of treating spinal internal disk derangement |
| 04/24/2008 | US20080096975 A copolymer of an N-alkyl acrylamide, preferably N-isopropyl acrylamide, (meth)acrylic acid, and an amine-reactive group and having a polyester macromer in the backbone; cell growth substrates, wound healing drug delivery; fluid below room temperature, gelation at physiological temperature; nontoxic |
| 04/24/2008 | US20080096974 Polyamine-Metal Chelator Conjugates |
| 04/24/2008 | US20080096967 Formulations for Injection of Catecholic Butanes, Including Ndga Compounds, Into Animals |
| 04/24/2008 | US20080096957 Albumin-Binding Conjugates Comprising a Fatty Acid and Peg |
| 04/24/2008 | US20080096858 Which is in an amorphous or other disordered state; freeze drying to remove water, heating within a given temperature range, optionally holding at heated temperature for up to two weeks, cooling |
| 04/24/2008 | US20080096854 Orally administering edible oil homogenized with edible wax and a sterol comprising stigmasterol, campesterol, p-sitosterol, chalinosterol, clionasterol, brassicasterol, alpha -spinasterol, daucosterol, desmosterol, and poriferasterol to treat colorectal, stomach, and/or esophagus cancer |
| 04/24/2008 | US20080096853 Reaction product of carboxylic acid(s) with glycerol and propylene glycol; co-lipid selected from phosphorus-containing lipids and hydroxylated carboxylic esters of mono- and di-glycerides; carotenoids, fat-soluble vitamins, phytosterols, and/or phytostanols; crystal structure; foods; beverages, soups |
| 04/24/2008 | US20080096852 Use of oculosurface selective glucocorticoid in the treatment of dry eye |
| 04/24/2008 | US20080096841 Using analogs of Lipid A such as Eritoran to treat or prevent mucositis, allograft/graft rejection, arteriosclerosis, atherosclerosis, hepatitis, asthma, and inflammatory bowel disease |
| 04/24/2008 | US20080096818 administering polypeptides comprising beta amyloid fragments, to induce immunogenic response against amyloid deposits; prophylaxios and therapy of Alzheimer's disease |
| 04/24/2008 | US20080095872 using modified Clostridial toxin having an orphanin targeting moiety, a domain for translocating a light chain across an endosome membrane; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 04/24/2008 | US20080095857 avidin-modified protein-based nanoparticles to which biotinylated antibodies are bound by forming a stable avidin-biotin complex; preferably human serum albumin is used as protein |
| 04/24/2008 | US20080095854 Ballast administering to mammals skins; high density core overcoated with amorphous reservoir containing dna; drug delivery; containing free radical scavenger |
| 04/24/2008 | US20080095852 exposing a catalyst to a reagent in the presence of a core particle, whereby the reagent reacts to form a layer on the core particle to form the layered nanoparticle |
| 04/24/2008 | US20080095841 Such as amlodipine besylate, iron oxide and carrageenan; storage stability |
| 04/24/2008 | US20080095839 Core contains acid-unstable drug and disintegrant, and release-controlling coating contains water-insoluble polymer, an enteric polymer and hydrophobic wax |
| 04/24/2008 | US20080095838 Solid pharmaceutical composition containing a lipophilic active principle and preparation method thereof |
| 04/24/2008 | US20080095826 Method of Increasing Peripheral Blood Lymphocytes |
| 04/24/2008 | US20080095824 Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space |
| 04/24/2008 | US20080095810 Nanoparticle systems for release of biologically active molecules formed by chitosan polymer or derivatives, chemically modified with polyethylene glycol and crosslinked with a crosslinking agent; especially useful for pharmaceutical compositions, vaccines and cosmetic formulations; controlled release |
| 04/24/2008 | US20080095802 Targeted delivery of cytotoxic drugs A) to activated lymphocytes in patients iwth transplanted organs, B) as radiosensitizers to cancer cells in paients undergoing radiation therapy, and C) in vitaminpbinding proteins as drug carriers in the diagnosis and treatment of cancer |
| 04/24/2008 | US20080095786 Compositions And Methods For Preventing And Treating Endotoxin-Related Diseases And Conditions |
| 04/24/2008 | US20080095736 Biocompatible polymers and hydrogels and methods of use |
| 04/24/2008 | DE102006049837A1 Use of core-shell or hollow microparticles containing superparamagnetic nanoparticles to treat blood vessel defects by application of a magnetic field |
| 04/24/2008 | CA2675499A1 Ophthalmic compositions containing diglycine |
| 04/24/2008 | CA2673526A1 Phenylalkyl carbamate compositions |
| 04/24/2008 | CA2673487A1 Phenylalkylamino carbamate compositions |
| 04/24/2008 | CA2672907A1 Pegylated pth as pth receptor modulators and uses thereof |
| 04/24/2008 | CA2666697A1 Block copolymer for drug conjugates and pharmaceutical composition |
| 04/24/2008 | CA2666587A1 Micellar nanoparticles of chemical substances |
| 04/24/2008 | CA2666398A1 Diclofenac gel |
| 04/23/2008 | EP1914237A2 Phosphonate ester antiviral compounds |
| 04/23/2008 | EP1913956A1 Compositons and methods for stablizing biological molecules upon lyophilization |
| 04/23/2008 | EP1913948A1 Re-epithelializing pharmaceutical compositions containing xanthan gum |
| 04/23/2008 | EP1913945A2 Composition based on a thiazolidinedione and metformin and its use |
| 04/23/2008 | EP1913939A1 Formulations for use in inhaler devices |
| 04/23/2008 | EP1913937A1 Guaifenesin sustained release formulation and tablets |
| 04/23/2008 | EP1913934A1 Emulgator-free plant oil containing an ophthalmic preparation |
| 04/23/2008 | EP1913026A1 Modified antibody fragments |
| 04/23/2008 | EP1912708A1 Emulsified skin external preparation and method for stabilizing the skin external preparation |
| 04/23/2008 | EP1912677A2 Psma antibody-drug conjugates |
| 04/23/2008 | EP1912676A2 Cyclitol linker polymer conjugate |
| 04/23/2008 | EP1912673A1 Process for attaching effector molecules to proteins |
| 04/23/2008 | EP1912669A2 Sustained release preparations of pro-insulin c-peptide |
| 04/23/2008 | EP1912651A2 Amorphous aprepitant coprecipitates |
| 04/23/2008 | EP1912621A1 Pharmaceutical composition containing indometacin and/or acemetacin |
| 04/23/2008 | EP1912516A2 Sensation masking composition |
| 04/23/2008 | EP1648527A4 Stabilization and ionic triggering of nitric oxide release |
| 04/23/2008 | EP1526835B1 Injectable depot compositions and uses thereof |
| 04/23/2008 | EP1420643B1 Enhancement of transfection of dna into the liver |
| 04/23/2008 | EP1418860B1 Oral care substance delivery strip |
| 04/23/2008 | EP1305064B1 Bioabsorbable composites of derivatized hyaluronic acid |
| 04/23/2008 | EP1261316B1 Device for the delivery of oral drugs |
| 04/23/2008 | EP1251871B1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and as adjuvants an immunogenic oligodeoxynucleotide and a polycationic polypeptide |
| 04/23/2008 | EP1242055B1 Hydrogel-driven drug dosage form |
| 04/23/2008 | EP1142591B1 Gene carriers |
| 04/23/2008 | CN101166763A Stabilized anti-hepatitis B (HBV) antibody formulations |
| 04/23/2008 | CN101166762A Albumin-fused Kunitz domain peptides |
| 04/23/2008 | CN101166753A Polymer conjugates of mutated neublastin |
| 04/23/2008 | CN101166545A GLP-1 pegylated compounds |
| 04/23/2008 | CN101166544A Fucoidan compositions and methods for dietary and nutritional supplements |
| 04/23/2008 | CN101166543A Composition containing antidementia agent |
| 04/23/2008 | CN101166531A Medicinal preparation for percutaneous absorption |
| 04/23/2008 | CN101164623A Compositions comprising viruses and methods for concentrating virus preparations |
| 04/23/2008 | CN101164622A Plant seed protein extract and use |
| 04/23/2008 | CN101164621A Super-paramagnetic composite particle drug-loaded body and preparation method thereof |
| 04/23/2008 | CN101164620A External preparation for skin |
| 04/23/2008 | CN101164619A Pyritinol injection with special purpose solvent |